A global pharmaceutical company achieves effective and efficient literature surveillance for targeted therapy areas

Recurring surveillance and reporting helped the client team stay abreast of changes/updates in the targeted therapy area for client and competitor molecules under development. Further, this hub model setup reduced the time and cost of delivering literature reviews. Quality improvements and enhanced audit readiness were achieved with enhanced visibility into the literature portfolio and team productivity.

Indegene is a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready.